EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.
EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification. Graefes Arch Clin Exp Ophthalmol. 2013 Jun; 251(6):1529-40.